Age (year)/gender | Blast (%) | Diagnosis | Cytogenetic findings | Overall survival (mo) | Reference |
---|---|---|---|---|---|
55/F | NA | MDS | 46,XX,inv(3)x2 | 24 | Walter [10] |
NA/F | NA | BP-CML | 46,XX,inv(3)x2,t(9;17;22) | NA | Levy [12] |
80/M | NA | AML-M1 | 46,XY,inv(3)x2 | 13 | Secker-Walker [8] |
39/M | NA | AML-M4 | 45,XY,inv(3)x2,-7 | 3 | Secker-Walker [8] |
83/F | 63 | AML | 45,XX,inv(3)x2,-7 | NA | Lee [7] |
65/M | 49 | AML-M4 | 46,XY,inv(3)x2, | 24 | Lahortiga [9] |
36/M | NA | CML | 46,XY,inv(3)x2,7q- | NA | Toydemir [11] |
62/M | 14 | AML-M1 | 45,XY,inv(3)x2,-7 | 9 | De Braekeleer [6] |
67/F | 35 | AML | 46,XX,inv(3),5q+/45,idem,-7/45,idem,inv(3),-7 | 4 | De Braekeleer [6] |
72/M | 79 | AML-M6A | 46,XY,inv(3)(q21q26.2),del(7)(q22)/46,XY,inv(3)(q21q26.2)x2 | 23 | Patient 1 |
64/F | 23 | AMML | 46,XX,inv(3)x2 | 12 | Patient 2 |
56/F | 54 | AML | 46,XX,inv(3)x2/45,idem,-7 | 5 | Patient 3 |